PTC Therapeutics Correlations

PTCT Stock

USD 50.96 0.60 1.19%

The current 90-days correlation between PTC Therapeutics and Krystal Biotech is 0.24 (i.e., Modest diversification). The correlation of PTC Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

PTC Therapeutics Correlation With Market

Average diversification

The correlation between PTC Therapeutics and DJI is 0.11 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding PTC Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PTC Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy PTC Stock please use our How to Invest in PTC Therapeutics guide.

Moving together with PTC Stock

0.63

CRSP

Crispr Therapeutics

Pair Corr

Moving against PTC Stock

0.64	NAMSW	NewAmsterdam Pharma	Pair Corr
0.45	XFOR	X4 Pharmaceuticals	Pair Corr
0.42	HLVX	Hillevax	Pair Corr
0.41	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.38	ILMN	Illumina	Pair Corr
0.36	DRMA	Dermata Therapeutics	Pair Corr
0.31	A	Agilent Technologies	Pair Corr
0.68	EMBC	Embecta Corp	Pair Corr
0.66	CGTX	Cognition Therapeutics	Pair Corr
0.74	PTITF	PT Indosat Tbk	Pair Corr
0.65	ADUS	Addus HomeCare	Pair Corr
0.46	U4R90AAB4	HLF 4875 01	Pair Corr
0.32	SSNLF	Samsung Electronics	Pair Corr

Related Correlations Analysis

	KRYS	SRPT	IOVA	MDGL	RETA	ICPT	BPMC	VKTX	HEPA
KRYS		0.23	0.56	0.19	0.0	0.0	-0.33	0.53	0.27	KRYS
SRPT	0.23		0.89	-0.41	0.0	0.0	-0.26	0.9	0.89	SRPT
IOVA	0.56	0.89		-0.29	0.0	0.0	-0.44	0.98	0.86	IOVA
MDGL	0.19	-0.41	-0.29		0.0	0.0	0.08	-0.32	-0.53	MDGL
RETA	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	RETA
ICPT	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	ICPT
BPMC	-0.33	-0.26	-0.44	0.08	0.0	0.0		-0.42	-0.54	BPMC
VKTX	0.53	0.9	0.98	-0.32	0.0	0.0	-0.42		0.89	VKTX
HEPA	0.27	0.89	0.86	-0.53	0.0	0.0	-0.54	0.89		HEPA
	KRYS	SRPT	IOVA	MDGL	RETA	ICPT	BPMC	VKTX	HEPA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

VKTX	+ 0.98	IOVA
VKTX	+ 0.9	SRPT
IOVA	+ 0.89	SRPT
HEPA	+ 0.89	SRPT
HEPA	+ 0.89	VKTX
HEPA	+ 0.86	IOVA

High negative correlations

HEPA	- 0.54	BPMC
HEPA	- 0.53	MDGL
BPMC	- 0.44	IOVA
VKTX	- 0.42	BPMC
MDGL	- 0.41	SRPT
BPMC	- 0.33	KRYS

Risk-Adjusted Indicators

There is a big difference between PTC Stock performing well and PTC Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze PTC Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
KRYS	2.21	(0.16)	0.00	2.69	0.00	0.00	3.05	(5.63)	15.53
SRPT	1.38	(0.36)	0.00	(0.95)	0.00	0.00	2.49	(4.38)	10.14
IOVA	2.67	(0.84)	0.00	(1.05)	0.00	0.00	4.99	(7.23)	17.35
MDGL	2.81	0.30	0.08	0.12	3.56	(2.97)	5.74	(5.25)	15.51
RETA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ICPT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
BPMC	2.00	(0.03)	0.00	(0.03)	0.00	0.00	5.39	(4.23)	26.30
VKTX	3.30	(0.97)	0.00	(2.32)	0.00	0.00	7.71	(12.73)	24.65
HEPA	8.07	(1.45)	0.00	(1.53)	0.00	0.00	29.41	(18.18)	86.86

PTC Therapeutics Corporate Management

Mark Boulding	Chief Legal Officer and Executive VP	Profile
Christine CPA	Chief VP	Profile
Christine Utter	Principal Financial Officer, Principal Accounting Officer, Treasurer	Profile
Lee MD	Executive Officer	Profile
Ellen Welch	Chief Officer	Profile
FACS FACS	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC